Archives of Dermatology · 2001 · 264 citations · 22 references
MedicineDermatologyPharmacotherapyChemotherapyDermatopathologyHypersensitivityDrug-induced Skin ReactionsHyperpigmentation TreatmentInflammatory DermatosesInflammatory Skin DiseasesAdverse Treatment EffectsLocalized HyperpigmentationMinocycline TherapyOral Tetracycline TherapyTreatment Adverse Effects
BACKGROUND: To evaluate the safety and efficacy of minocycline in the treatment of sarcoidosis, a nonrandomized, open study was performed in patients with cutaneous sarcoidosis. OBSERVATIONS: Twelve patients with cutaneous sarcoidosis were treated with minocycline, 200 mg/d, for a median duration of 12 months. Three patients had extracutaneous lesions at the time of the study. The median follow-up was 26 months. A clinical response was observed in 10 patients, consisting of complete responses in 8 patients and partial responses in 2 patients. A progression of skin lesions was observed in 1 patient, and lesions remained stable in another patient. Adverse effects were minimal, except in 1 patient, who developed hypersensitivity syndrome. A slight hyperpigmentation occurred in 2 patients at the site of previous lesions, which completely disappeared after minocycline use was discontinued. A relapse of skin symptoms occurred after minocycline withdrawal in 3 patients, who further received doxycycline, 200 mg/d, allowing a complete remission of lesions. CONCLUSIONS: These results support that minocycline and doxycycline may be beneficial for the treatment of cutaneous sarcoidosis. Randomized controlled studies are warranted for the evaluation of the true efficacy of tetracyclines in these patients.
22
Prognostic Factors Predicting the Outcome of Sarcoidosis: An Analysis of 818 Patients
E Neville, A. N. Walker, David G. James · QJM · 1983 · 326 citations
Medicine, Dermatology, Pathology +14
Prolonged Use of Methotrexate for Sarcoidosis
Elyse E. Lower · Archives of Internal Medicine · 1995 · 302 citations